SOC Telemed to be Acquired by Patient Square Capital

Go back to SOC Telemed to be Acquired by Patient Square Capital

RBC Capital Downgrades SOC Telemed (TLMD) to Sector Perform

February 3, 2022 9:13 AM EST

RBC Capital analyst Sean Dodge downgraded SOC Telemed (NASDAQ: TLMD) from Outperform to Sector Perform with a price target of $3.00 (from $6.00).

The analyst comments "This morning SOC Telemed (TLMD) announced an agreement to be acquired by Patient Square Capital (private) for $3/share... More